Assam, India

Gakul Baishya

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2014.



Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gakul Baishya: Innovator in Artemisinin Derivatives

Introduction

Gakul Baishya is a notable inventor based in Assam, India. He has made significant contributions to the field of medicinal chemistry, particularly in the synthesis of artemisinin derivatives. His work focuses on developing novel compounds that have potential applications in cancer treatment.

Latest Patents

Gakul Baishya holds a patent for a series of artemisinin derivatives and the process for their preparation. This invention relates to the synthesis of certain novel Baylis-Hillman adducts of artemisinin derived aldehyde 2-[10'β-deoxoartemisininyl]-ethanal. The capabilities of introducing three functional groups into a molecule in one step using the Baylis-Hillman reaction encouraged him to synthesize some highly functionalized derivatives of artemisinin. These derivatives have shown activity against various cancer cell lines, highlighting their potential therapeutic benefits.

Career Highlights

Gakul Baishya is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research in medicinal chemistry. His innovative approach to synthesizing artemisinin derivatives has positioned him as a key figure in the field.

Collaborations

He has collaborated with notable colleagues such as Ajit Kumar Saxena and Abhishek Goswami, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Gakul Baishya's work in the synthesis of artemisinin derivatives represents a significant advancement in cancer research. His contributions are paving the way for new therapeutic options in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…